Although the status of the genes involved in HR was not evaluated in tumors tested in this study, these results suggest that another potential mechanism of resistance to anti-tumor effects of PARP inhibitors may involve regulation of PARP itself. This evidence concerns the gene PARP1 and neoplasm.